LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia

Photo from wikipedia

Antiepileptic drugs are the first‐line treatment for trigeminal neuralgia (TN). Carbamazepine and oxcarbazepine are the most studied with well‐known efficacy. Eslicarbazepine acetate is a third‐generation antiepileptic drug that has not… Click to show full abstract

Antiepileptic drugs are the first‐line treatment for trigeminal neuralgia (TN). Carbamazepine and oxcarbazepine are the most studied with well‐known efficacy. Eslicarbazepine acetate is a third‐generation antiepileptic drug that has not previously been evaluated for the treatment of TN. We aim to assess the efficacy, tolerability and safety of eslicarbazepine for TN.

Keywords: treatment; treatment trigeminal; efficacy; safety eslicarbazepine; trigeminal neuralgia; eslicarbazepine acetate

Journal Title: European Journal of Pain
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.